Appendiceal Intussusception Secondary to Mantle Cell Lymphoma: A Report of a Rare Case.

OA: gold CC-BY-4.0
AI-generated summary by gemini-2.5-flash-lite, 2026-08-04

This case report describes a rare instance of appendiceal intussusception caused by mantle cell lymphoma in a 68-year-old male, diagnosed after a hemicolectomy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-07, 2026-07-04 · read from full text

This case report describes a 68-year-old man with intermittent right lower quadrant pain for three weeks, found on ultrasound and CT to have appendiceal intussusception, who underwent laparoscopic-assisted right hemicolectomy to address a dilated appendix acting as the lead point. Histopathology and immunohistochemistry showed mantle cell lymphoma involving the entire appendix and extending into the caecum, with CD5, CD20, cyclin D1, and SOX11 positivity, a Ki-67 index of 40–50%, and strong diffuse p53 positivity consistent with a pleomorphic/aggresive variant; all sampled mesenteric nodes (n=28) were involved. The authors note that preoperative identification of the underlying pathology is difficult, and a normal colonoscopy eight months earlier did not rule out rapidly evolving appendiceal disease. Relevance to endometriosis: the paper mentions endometriosis as a more frequently reported (than lymphoma) cause of appendiceal intussusception, though this specific report is about mantle cell lymphoma.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma that can involve the gastrointestinal (GI) tract. Appendiceal involvement, however, is highly uncommon. Appendiceal intussusception is a rare entity, accounting for only a small fraction of appendicectomy findings. We present a rare case of a 68-year-old male who developed appendiceal intussusception secondary to mantle cell lymphoma, diagnosed following laparoscopic right hemicolectomy. To the best of our knowledge, this is the first reported case of MCL manifesting with appendiceal intussusception. This report emphasises the significance of considering lymphoproliferative disorders in elderly patients presenting with persistent right lower quadrant pain and imaging suggestive of intussusception.
Full text 8,459 characters · extracted from pmc-nxml · 4 sections · click to expand

Cases

A 68-year-old male presented to the emergency department with a three-week history of intermittent, dull, colicky right lower quadrant abdominal pain. He denied nausea, vomiting, diarrhoea, or melena but reported a decrease in oral intake and mild constipation. He had no fever or systemic symptoms apart from longstanding fatigue and unintentional weight loss over several years. His medical history was notable for a colonoscopy performed eight months prior for altered bowel habits, which revealed a normal terminal ileum, caecum, and appendiceal orifice, with excellent bowel preparation. His family history included bowel cancer in both his father and sister. He was an ex-smoker, abstinent from alcohol, and had no prior abdominal surgeries. On examination, the patient was found to be haemodynamically stable, afebrile, and exhibiting no signs of acute distress. Abdominal examination revealed tenderness in the right iliac fossa without guarding, rebound tenderness, or palpable mass. Blood tests indicated normal haemoglobin levels, normal white cell count and differential, and normal biochemistry profiles. An abdominal ultrasound demonstrated a target sign in the right lower quadrant, indicative of intussusception (Figure 1 ). Computed tomography (CT) of the abdomen and pelvis reported as intussusception at the ileocecal junction (Figure 2 ). The patient was subsequently admitted to the surgical unit and underwent a laparoscopic-assisted right hemicolectomy. An arrow indicates intestinal intussusception in the right lower quadrant. An arrow indicates intestinal intussusception in the right lower quadrant. Intraoperative findings revealed a significantly dilated appendix that had undergone intussusception into the caecum (Figures 3 - 5 ). There was no evidence of ileocolic intussusception, free mucus, or peritoneal dissemination. The rest of the bowel appeared normal. The postoperative course was uneventful. The yellow arrow indicates the appendix, and the green arrow indicates the appendiceal intussusception into the caecum. The yellow arrow indicates the appendix, and the green arrow indicates the appendiceal intussusception into the caecum. The yellow arrow indicates the appendix, and the green arrow indicates the appendiceal intussusception into the caecum. Histopathology revealed a dense infiltrate of intermediate to large, atypical lymphocytes involving the entire appendix and extending into the caecum (Figure 6 ). The neoplastic lymphoid infiltrate had a pushing border and obliterated the mucosa and submucosa. There was no evidence of invasion into the serosa or mesenteric fat. A total of 28 mesenteric lymph nodes were sampled, with all demonstrating involvement by mantle cell lymphoma, including the apical node. Specimen showing atypical lymphocytes with moderate nuclear pleomorphism (the arrow indicates one of many atypical lymphocytes). Immunohistochemistry demonstrated positivity for CD5, CD20, Bcl2, Cyclin D1, and SOX11, while it showed negativity for CD3, CD10, Bcl6, CD23, and EBER (Figure 7 ). The Ki-67 proliferation index was between 40% and 50%, and p53 exhibited strong diffuse positivity, consistent with a pleomorphic variant of MCL. A: CD5; B: CD20; C: Cyclin D1; D: SOX11 Postoperatively, the patient underwent staging with positron emission tomography-computed tomography (PET-CT), which revealed asymmetrical fluorodeoxyglucose (FDG) uptake in the left tonsil and physiological uptake in the colon (Figure 8 ). He was commenced on R-DHAOx (rituximab, dexamethasone, cytarabine, oxaliplatin) and completed four cycles, followed by maintenance rituximab. The yellow arrow indicates fluorodeoxyglucose (FDG) uptake in the left tonsil, while the green arrow indicates physiological FDG uptake in the colon. PET-CT: Positron emission tomography-computed tomography. Surveillance colonoscopy at 15 months after surgery revealed a healthy ileocolic anastomosis with no signs of recurrence (Figure 9 ). An 18-month PET scan demonstrated persistent uptake in the left tonsil but no other abnormalities (Figure 10 ). The patient remains clinically well and in remission. X: Ileum; Y: Colon; The arrows indicate a healthy ileocolic anastomosis. The yellow arrow indicates persistent fluorodeoxyglucose (FDG) uptake in the left tonsil. PET-CT: Positron emission tomography-computed tomography.

Intro

Mantle cell lymphoma (MCL) accounts for approximately 5-7% of non-Hodgkin lymphomas and is frequently characterised by an aggressive clinical progression [ 1 - 3 ]. It originates from naive B-cells within the mantle zone and is commonly associated with cyclin D1 overexpression due to the t(11;14)(q13;q32) translocation [ 3 - 5 ]. The gastrointestinal (GI) tract is a common extranodal site, identified in up to 30% of cases via endoscopic biopsy; however, presentation within the appendix is exceedingly rare [ 6 - 8 ]. Appendiceal intussusception is an infrequent occurrence, observed in only 0.01% of patients undergoing appendicectomy [ 9 - 11 ]. It may be caused by benign or malignant lesions serving as a lead point. While inflammation and endometriosis are more frequently implicated [ 12 , 13 ], MCL as an etiological factor has not been previously documented. To the authors' knowledge, based on a comprehensive review of the existing literature, this report presents the first known case of appendiceal intussusception attributable to mantle cell lymphoma.

Discussion

MCL is a rare and clinically aggressive lymphoma subtype with heterogeneous presentation [ 1 - 3 ]. Gastrointestinal (GI) involvement, while relatively common, is rarely symptomatic and even more infrequently detected in the appendix [ 6 - 8 ]. Studies have demonstrated that GI manifestations can range from subtle mucosal abnormalities to frank mass lesions, often mimicking other pathologies such as adenocarcinoma or Crohn's disease [ 14 , 15 ]. Appendiceal intussusception, frequently presenting as right lower quadrant pain, can be attributable to a lead point such as mucoceles, polyps, or neoplasms. Park et al. described a case involving an appendiceal mucocele causing intussusception that was successfully reduced via colonoscopy [ 10 ]. Endometriosis has also been documented as an aetiology in females, as highlighted by Trefois and Coche [ 12 ]. Malignant causes are rare, with lymphoma being infrequently implicated [ 13 ]. Our case is notable for its uniqueness; mantle cell lymphoma acting as a lead point for intussusception has not been previously documented. A similar case involving MCL and the appendix was reported by Mamukadze et al., where the patient presented with volvulus rather than intussusception [ 16 ]. Lee et al. described MCL mimicking acute appendicitis, emphasising the diagnostic challenges [ 17 ]. Radiologically, the target sign observed on computed tomography (CT) or ultrasound is characteristic of intussusception [ 18 ]. However, preoperative identification of the underlying pathology remains difficult. As demonstrated in our case, a normal colonoscopy performed eight months prior may not preclude rapidly evolving appendiceal pathology. Histopathological confirmation remains the gold standard, with immunohistochemistry being critical for diagnosis. MCL typically expresses CD5, CD20, Cyclin D1, and SOX11 [ 3 - 5 ]. A high Ki-67 index and strong p53 expression, as observed in our patient, suggest a pleomorphic or aggressive variant, which correlates with a poorer prognosis [ 19 , 20 ]. Therapeutic strategies for MCL vary based on stage and presentation. Surgical resection is essential for localised disease or complications such as intussusception. Systemic chemotherapy, including rituximab-based regimens (e.g., R-CHOP, R-DHAOx), is standard. Maintenance rituximab has demonstrated survival benefits in responders [ 3 ]. Long-term surveillance is crucial due to the risk of relapse. PET-CT remains the imaging modality of choice for post-treatment monitoring, as metabolic activity often predates anatomical changes [ 21 ].

Conclusions

This case represents the first report of appendiceal intussusception secondary to mantle cell lymphoma. It emphasises the diagnostic difficulty associated with uncommon aetiologies of abdominal pain and underscores the significance of histopathological evaluation in resected specimens. Clinicians should maintain a heightened suspicion of lymphoma in elderly individuals presenting with atypical gastrointestinal symptoms and intussusception.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: pmc-nxml

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-08-16T09:21:09.727480+00:00
unpaywall
last seen: 2026-05-21T05:10:58.409756+00:00
License: CC-BY-4.0